STERIS’ (TSE:STE – Free Report) – Research analysts at Atb Cap Markets increased their Q1 2027 earnings estimates for shares of STERIS’ in a report released on Wednesday, June 11th. Atb Cap Markets analyst W. Syed now anticipates that the company will post earnings per share of $0.49 for the quarter, up from their previous forecast of $0.46. Atb Cap Markets also issued estimates for STERIS’’s FY2027 earnings at $1.04 EPS.
Separately, Raymond James lowered shares of STERIS’ from a “moderate buy” rating to a “hold” rating in a research note on Wednesday, April 9th.
STERIS’ Price Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Articles
- Five stocks we like better than STERIS’
- How to buy stock: A step-by-step guide for beginners
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- What Does Downgrade Mean in Investing?
- Alphabet Enters a Bull Market: Is It Time to Buy?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.